Microbiome Therapeutics: Out of Range or Just Under the Radar? genengnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from genengnews.com Daily Mail and Mail on Sunday newspapers.
Vedanta Biosciences Key Microbiome Patents Fully Upheld in Three European Opposition Proceedings finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
The microbiome therapeutic developer Vedanta Biosciences has raked in $106.5m to bankroll the launch of a phase 3 trial of its lead candidate, VE303, for the prevention of recurrent Clostridioides difficile infection (CDI).
A company developing a potential new category of oral therapies based on defined bacterial consortia has made two big announcements this week (April 25).
A company developing a potential new category of oral therapies based on defined bacterial consortia has made two big announcements this week (April 25).